(Q43511346)

24 November 2017

title

Helicobacter pylori eradication: A new, single-capsule bismuth-containing quadruple therapy (English)

1 reference

24 November 2017

1 reference

1 reference

1

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 June 2011

1 reference

Nature Reviews Gastroenterology & Hepatology

24 November 2017

published in

1 reference

24 November 2017

volume

8

1 reference

24 November 2017

issue

6

1 reference

24 November 2017

page(s)

307-309

1 reference

Helicobacter pyloriInfection

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.84

Treatment of Helicobacter pylori infection 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.84

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.84

H pylori antibiotic resistance: prevalence, importance, and advances in testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.84

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.84

Efficacy and safety of single-triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.84

Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta‐analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.84

Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.84

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.84

Quadruple or triple therapy to eradicate H pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2011.84

Sequential therapy for Helicobacter pylori eradication: a critical review

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21643037

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patien

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21643037

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRGASTRO.2011.84

1 reference

24 November 2017

1 reference